Regeneron Pharmaceuticals revenue and financials
In the fiscal year ended December 2025, Regeneron Pharmaceuticals reported revenue of $14.34B (+0.99% year over year). Net income was $4.5B, a net margin of 31.4%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +0.99%
- 2025 vs 2024
- Net income growth
- +2.09%
- 2025 vs 2024
- Net margin
- 31.4%
- 2024: 31.1%
How Regeneron Pharmaceuticals is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 11.0% a year on average over the last 5 years
Compound annual growth rate: from $8.5B in 2020 to $14.34B in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 38.9% to 24.9%
Operating income over revenue, 2022 → 2025: 14.0 percentage points.
Profits turn into cash: free cash flow equal to 90% of net income
Totals for fiscal years 2023–2025: free cash flow $11.62B, net income $12.87B.
Shares outstanding down 5.6% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14,343 | 14,202 | 13,117 | 12,173 | 16,072 | 8,497 | 6,558 | 5,146 | 5,872 | 4,860 |
| Cost of revenue | 7,951 | 7,103 | 6,255 | 5,153 | 5,298 | 3,767 | 403 | 238 | 203 | 195 |
| Gross profit | 6,392 | 7,100 | 6,862 | 7,020 | 10,774 | 4,730 | 3,343 | 3,259 | 3,400 | 2,508 |
| Selling, general and administrative | 2,700 | 2,954 | 2,631 | 2,116 | 1,825 | 1,346 | 1,342 | 1,127 | 1,320 | 1,178 |
| Research and development | 5,850 | 5,132 | 4,439 | 3,593 | 2,860 | 2,647 | 2,450 | 1,469 | 2,075 | 2,052 |
| Operating income | 3,578 | 3,991 | 4,047 | 4,739 | 8,947 | 3,577 | 2,210 | 2,534 | 2,080 | 1,331 |
| EBIT | 3,702 | 4,145 | 4,233 | 4,994 | 8,995 | 3,665 | 2,210 | 2,534 | 2,080 | 1,331 |
| EBITDA | 4,246 | 4,628 | 4,654 | 5,335 | 9,281 | 3,901 | 2,420 | 2,683 | 2,225 | 1,435 |
| Interest expense | 43.8 | 55.2 | 73.0 | 59.4 | 57.3 | 56.9 | 30.2 | 28.2 | 25.1 | 7.2 |
| Pre-tax income | 5,231 | 4,780 | 4,199 | 4,859 | 9,326 | 3,810 | 2,429 | 2,554 | 2,079 | 1,330 |
| Income tax | 726 | 367 | 246 | 520 | 1,251 | 297 | 313 | 109 | 880 | 434 |
| Net income | 4,505 | 4,413 | 3,954 | 4,338 | 8,075 | 3,513 | 2,116 | 2,444 | 1,199 | 896 |
| Net income to common shareholders | 4,505 | 4,413 | 3,954 | 4,338 | 8,075 | 3,513 | 2,116 | 2,444 | 1,199 | 896 |
| Basic EPS | 43.07 | 40.90 | 37.05 | 40.51 | 76.40 | 32.65 | 19.38 | 22.65 | 11.27 | 8.55 |
| Diluted EPS | 41.48 | 38.34 | 34.77 | 38.22 | 71.97 | 30.52 | 18.46 | 21.29 | 10.34 | 7.70 |
| Average shares (basic) | 105 | 108 | 107 | 107 | 106 | 108 | 109 | 108 | 106 | 105 |
| Average shares (diluted) | 109 | 115 | 114 | 114 | 112 | 115 | 115 | 115 | 116 | 116 |
| Dividend per share | 3.52 | — | — | — | — | — | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5,116 | 4,291 | 3,605 | 3,884 | 3,754 | 3,676 | 3,029 | 3,789 | 3,721 | 3,547 | 3,145 | 3,434 |
| Cost of revenue | 574 | 2,208 | 2,213 | 2,211 | 1,997 | 1,952 | 1,792 | 1,978 | 1,763 | 1,680 | 1,682 | 1,694 |
| Gross profit | 4,542 | 2,083 | 1,393 | 1,674 | 1,758 | 1,724 | 1,237 | 1,812 | 1,958 | 1,867 | 1,463 | 1,740 |
| Selling, general and administrative | 678 | 662 | 648 | 775 | 658 | 634 | 633 | 792 | 714 | 759 | 689 | 738 |
| Research and development | 1,795 | 1,632 | 1,544 | 1,626 | 1,475 | 1,432 | — | — | — | — | — | — |
| Operating income | 2,070 | 1,421 | 745 | 899 | 1,110 | 1,090 | 604 | 1,020 | 1,244 | 1,108 | 774 | 1,003 |
| EBIT | 2,070 | 1,421 | 745 | 899 | 1,110 | 1,090 | 604 | 1,020 | 1,244 | 1,108 | 774 | 1,003 |
| EBITDA | 2,193 | 1,544 | 868 | 1,044 | 1,247 | 1,225 | 731 | 1,146 | 1,365 | 1,229 | 888 | 1,116 |
| Interest expense | 10.6 | 11.0 | 12.9 | 12.2 | 19.3 | 3.6 | 8.7 | 10.5 | 13.8 | 14.8 | 16.1 | 18.3 |
| Pre-tax income | 2,284 | 1,528 | 831 | 1,044 | 1,763 | 1,519 | 905 | 958 | 1,493 | 1,628 | 701 | 1,148 |
| Income tax | 335 | 231 | 104 | 199 | 303 | 127 | 96.3 | 40.4 | 152 | 196 | -21.3 | -12.0 |
| Net income | 1,949 | 1,297 | 727 | 845 | 1,460 | 1,392 | 809 | 918 | 1,341 | 1,432 | 722 | 1,160 |
| Net income to common shareholders | 1,949 | 1,297 | 727 | 845 | 1,460 | 1,392 | 809 | 918 | 1,341 | 1,432 | 722 | 1,160 |
| Basic EPS | 19.16 | 12.62 | 6.99 | 8.21 | 14.09 | 13.24 | 7.58 | 8.53 | 12.40 | 13.25 | 6.70 | 10.88 |
| Diluted EPS | 18.45 | 12.23 | 6.75 | 7.86 | 13.62 | 12.81 | 7.27 | 8.07 | 11.54 | 12.41 | 6.27 | 10.19 |
| Average shares (basic) | 102 | 103 | 104 | 103 | 104 | 105 | 107 | 108 | 108 | 108 | 108 | 107 |
| Average shares (diluted) | 106 | 106 | 108 | 108 | 107 | 109 | 111 | 114 | 116 | 115 | 115 | 114 |
| Dividend per share | — | 0.94 | 0.94 | 0.88 | 0.88 | 0.88 | 0.88 | — | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40,559 | 37,759 | 33,080 | 29,215 | 25,435 | 17,163 | 14,805 | 11,735 | 8,764 | 6,973 |
| Current assets | 18,022 | 18,661 | 19,479 | 15,884 | 14,015 | 9,779 | 7,689 | 6,448 | 4,335 | 3,180 |
| Cash and equivalents | 3,118 | 2,488 | 2,730 | 3,106 | 2,886 | 2,194 | 1,618 | 1,468 | 813 | 535 |
| Short-term investments | 5,487 | 6,524 | 8,115 | 4,636 | 2,809 | 1,393 | 1,597 | 1,342 | 597 | 503 |
| Receivables | 5,741 | 6,212 | 5,667 | 5,329 | 6,037 | 4,115 | 2,786 | 2,272 | 2,046 | 1,612 |
| Inventory | 3,201 | 3,087 | 2,581 | 2,402 | 1,951 | 1,917 | 1,416 | 1,151 | 726 | 399 |
| Net property, plant and equipment | 5,366 | 4,817 | 4,224 | 3,834 | 3,482 | 3,222 | 2,890 | 2,576 | 2,359 | 2,083 |
| Other intangible assets | 1,257 | 1,149 | 1,039 | 916 | 6.7 | — | — | — | — | — |
| Long-term investments | 10,595 | 9,060 | 5,471 | 6,640 | 6,878 | 3,195 | 3,312 | 1,801 | 1,524 | 864 |
| Current liabilities | 4,368 | 3,944 | 3,423 | 3,141 | 3,933 | 2,697 | 2,097 | 1,443 | 1,136 | 1,241 |
| Accounts payable | 939 | 790 | 607 | 589 | 564 | 476 | 418 | 218 | 178 | 135 |
| Long-term debt | 1,986 | 1,984 | 1,983 | 1,981 | 1,980 | 1,979 | — | — | — | — |
| Total debt | 2,973 | 2,939 | 2,791 | 2,770 | 2,700 | 2,696 | 714 | 709 | 704 | 481 |
| Total liabilities | 9,302 | 8,406 | 7,107 | 6,551 | 6,666 | 6,138 | 3,716 | 2,977 | 2,620 | 2,524 |
| Total equity (incl. minority) | 31,257 | 29,354 | 25,973 | 22,664 | 18,769 | 11,025 | 11,090 | 8,757 | 6,144 | 4,449 |
| Retained earnings | 35,797 | 31,673 | 27,260 | 23,307 | 18,968 | 10,893 | 7,380 | 5,254 | 2,947 | 1,748 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 44,405 | 41,731 | 40,869 | 40,559 | 40,169 | 38,219 | 37,545 | 37,759 | 37,442 | 36,087 | 34,370 | 33,080 |
| Current assets | 29,332 | 18,446 | 18,209 | 18,022 | 17,981 | 16,860 | 17,572 | 18,661 | 19,334 | 19,082 | 18,872 | 19,479 |
| Cash and equivalents | 18,859 | 2,456 | 2,963 | 3,118 | 2,506 | 1,996 | 3,090 | 2,488 | 2,012 | 1,921 | 2,602 | 2,730 |
| Short-term investments | — | 5,539 | 5,791 | 5,487 | 5,937 | 5,474 | 5,259 | 6,524 | 7,785 | 7,888 | 7,918 | 8,115 |
| Receivables | 7,579 | 6,565 | 5,731 | 5,741 | 5,687 | 5,610 | 5,561 | 6,212 | 6,107 | 5,717 | 5,222 | 5,667 |
| Inventory | 2,895 | 3,084 | 3,104 | 3,201 | 3,254 | 3,206 | 3,192 | 3,087 | 3,018 | 2,874 | 2,715 | 2,581 |
| Net property, plant and equipment | 5,728 | 5,459 | 5,266 | 5,366 | 5,002 | 4,841 | 4,694 | 4,817 | 4,439 | 4,306 | 4,226 | 4,224 |
| Other intangible assets | 1,316 | 1,310 | 1,287 | 1,257 | 1,381 | 1,352 | 1,167 | 1,149 | 1,120 | 1,102 | 1,059 | 1,039 |
| Long-term investments | — | 10,630 | 10,528 | 10,595 | 10,701 | 10,467 | 9,665 | 9,060 | 8,651 | 7,919 | 7,053 | 5,471 |
| Current liabilities | 7,230 | 5,531 | 5,108 | 4,368 | 4,425 | 3,667 | 3,567 | 3,944 | 3,661 | 3,509 | 3,581 | 3,423 |
| Accounts payable | 7,230 | 1,159 | 1,027 | 939 | 904 | 724 | 706 | 790 | 497 | 562 | 671 | 607 |
| Long-term debt | 1,987 | 1,987 | 1,986 | 1,986 | 1,986 | 1,985 | 1,985 | 1,984 | 1,984 | 1,984 | 1,983 | 1,983 |
| Total debt | — | 2,707 | 2,706 | 2,973 | 2,706 | 2,705 | 2,705 | 2,939 | 2,704 | 2,704 | 2,703 | — |
| Total liabilities | 10,907 | 10,019 | 9,445 | 9,302 | 9,212 | 8,280 | 8,158 | 8,406 | 8,116 | 7,881 | 7,379 | 7,107 |
| Total equity (incl. minority) | 33,499 | 31,711 | 31,424 | 31,257 | 30,958 | 29,939 | 29,388 | 29,354 | 29,326 | 28,206 | 26,991 | 25,973 |
| Retained earnings | — | 37,621 | 36,424 | 35,797 | 35,046 | 33,680 | 32,384 | 31,673 | 30,755 | 29,415 | 27,982 | 27,260 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4,979 | 4,421 | 4,594 | 5,015 | 7,081 | 2,618 | 2,430 | 2,195 | 1,307 | 1,486 |
| Depreciation and amortization | 544 | 483 | 421 | 341 | 286 | 236 | 210 | 148 | 146 | 105 |
| Capital expenditure | -898 | -756 | -719 | -590 | -552 | -615 | -430 | -383 | -273 | -512 |
| Investing cash flow | -629 | -2,468 | -3,185 | -3,785 | -5,385 | -70.6 | -2,028 | -1,463 | -1,005 | -1,047 |
| Financing cash flow | -3,715 | -2,201 | -1,790 | -1,009 | -1,006 | -1,971 | -252 | -77.1 | -24.4 | -701 |
| Dividends paid | -370 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Share repurchases | -3,439 | -2,603 | -2,235 | -2,083 | -1,645 | -5,847 | -276 | -4.4 | 0.0 | 0.0 |
| Debt issued | — | — | — | 0.0 | 0.0 | 3,482 | — | — | 57.0 | 5.1 |
| Debt repaid | — | — | — | 0.0 | 0.0 | -1,500 | — | — | -19.9 | -45.7 |
| Effect of exchange rates | 0.3 | -0.7 | -0.4 | 0.0 | — | — | — | — | — | — |
| Net change in cash | 635 | -249 | -382 | 221 | 691 | 577 | 150 | 655 | 278 | -261 |
| Free cash flow | 4,081 | 3,665 | 3,875 | 4,425 | 6,529 | — | — | — | — | — |
| Levered free cash flow | 3,258 | 2,636 | 2,763 | 2,628 | 4,309 | 1,192 | 1,424 | 1,354 | 904 | 1,022 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 813 | 1,079 | 1,171 | 1,619 | 1,144 | 1,045 | 1,263 | 1,291 | 354 | 1,513 | 1,090 | 1,114 |
| Depreciation and amortization | 124 | 123 | 145 | 137 | 135 | 127 | 126 | 122 | 121 | 114 | 113 | 105 |
| Capital expenditure | -240 | -231 | -249 | -201 | -219 | -229 | -200 | -242 | -181 | -134 | -251 | -176 |
| Investing cash flow | -92.7 | -429 | 220 | -403 | -1,094 | 648 | 351 | -574 | -557 | -1,687 | -66.2 | -496 |
| Financing cash flow | -1,225 | -802 | -780 | -718 | -1,128 | -1,089 | -1,136 | -634 | -478 | 47.1 | -446 | -407 |
| Dividends paid | -96.8 | -97.8 | -92.7 | -91.2 | -92.6 | -93.8 | — | — | — | — | — | — |
| Share repurchases | -1,177 | -868 | -1,191 | -667 | -1,067 | -1,046 | -1,226 | -855 | -916 | -635 | -747 | -676 |
| Effect of exchange rates | -0.3 | -0.9 | -0.3 | -0.4 | 0.4 | 0.6 | -0.7 | 0.8 | -0.3 | -0.5 | 0.2 | -0.2 |
| Net change in cash | -505 | -153 | 611 | 498 | -1,077 | 604 | 477 | 83.6 | -682 | -128 | 578 | 211 |
| Free cash flow | 573 | 848 | 922 | 1,417 | 925 | 816 | 1,063 | 1,049 | 174 | 1,379 | 838 | 938 |
| Levered free cash flow | 383 | 577 | 684 | 1,422 | 591 | 562 | 936 | 761 | -177 | 1,115 | 548 | 623 |
Financial statements of similar companies
Companies in the group: same industry, similar size
